title: OKT3 as prophylaxis immunosuppression in pediatric liver transplant recipients.
authors.affiliation: Department of Pediatrics and Surgery, University and Children's Hospital of Western Ontario, London, Canada.
authors.forename: J F
authors.initials: JF
authors.lastname: Sommerauer
authors.forename: P
authors.initials: P
authors.lastname: Atkison
authors.forename: J
authors.initials: J
authors.lastname: Howard
authors.forename: D
authors.initials: D
authors.lastname: Grant
authors.forename: W
authors.initials: W
authors.lastname: Wall
mesh_terms: D000293:Adolescent; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007223:Infant; D016031:Liver Transplantation / Q000009:adverse effects / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology*; D016176:T-Lymphocyte Subsets / Q000276:immunology
chemical_list: D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D008775:Methylprednisolone